UB Paderborn / Katalog / Suche / in CDI

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3606-3610

2015

Volltextzugriff (PDF)

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3280-3284

2009

Volltextzugriff (PDF)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013

Annals of clinical microbiology and antimicrobials, 2015-05, Vol.14 (1), p.27-27, Article 27

2015

Volltextzugriff (PDF)

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3043-3046

2010

Volltextzugriff (PDF)

Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

Journal of global antimicrobial resistance., 2022-09, Vol.30, p.23-30

2022

Volltextzugriff (PDF)

Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3917-3921

2011

Volltextzugriff (PDF)

In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Volltextzugriff (PDF)

Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3031-3034

2010

Volltextzugriff (PDF)

Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.1067-1078

2016

Volltextzugriff (PDF)

In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013

Antimicrobial agents and chemotherapy, 2015-07, Vol.59 (7), p.4239-4248

2015

Volltextzugriff (PDF)

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.670-677

2016

Volltextzugriff (PDF)

Susceptibility of Staphylococcus aureus to Topical Agents in the United States: A Sentinel Study

Clinical therapeutics, 2014-06, Vol.36 (6), p.953-960

2014

Volltextzugriff (PDF)

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2018-07, Vol.62 (7)

2018

Volltextzugriff (PDF)

Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.4490-4500

2016

Volltextzugriff (PDF)

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.4677-4683

2016

Volltextzugriff (PDF)

In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016

Diagnostic microbiology and infectious disease, 2017-10, Vol.89 (2), p.151-157

2017

Volltextzugriff (PDF)

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.343-347

2016

Volltextzugriff (PDF)

In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (1), p.162-169

2016

Volltextzugriff (PDF)

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009

International journal of antimicrobial agents, 2011-03, Vol.37 (3), p.219-224

2011

Volltextzugriff (PDF)

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002

Diagnostic microbiology and infectious disease, 2005-04, Vol.51 (4), p.291-295

2005

Volltextzugriff (PDF)

Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)

JAC-antimicrobial resistance, 2022-06, Vol.4 (3), p.dlac060-dlac060

2022

Volltextzugriff (PDF)

In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012–2014

Diagnostic microbiology and infectious disease, 2016-10, Vol.86 (2), p.194-199

2016

Volltextzugriff (PDF)

Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008–2012. Results of the Study for Monitoring Antimicrobial Resistance Trends

Diagnostic microbiology and infectious disease, 2015-07, Vol.82 (3), p.209-214

2015

Volltextzugriff (PDF)

Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units-Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010

The Pediatric infectious disease journal, 2013-06, Vol.32 (6), p.636-640

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems

Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Susceptibility of Staphylococcus aureus to Topical Agents in the United States: A Sentinel Study

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015

Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015

Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014

In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program

In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002

Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018–20)

In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012–2014

Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008–2012. Results of the Study for Monitoring Antimicrobial Resistance Trends

Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units-Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010

Suchergebnisse filtern